Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced 24 April 2018
1 Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy 24 April 2018
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States 24 April 2018
Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018 24 April 2018
Cerbios-Pharma SA – Enterococcus faecium SF68®: a model for efficacy and safety for Pharmaceutical Probiotics 20 April 2018
Helsinn Provides Grant for ESMO’s Preceptorship Programme for Supportive and Palliative Care 12 April 2018
APR Applied Pharma Research – PKU Management: insights from a global market research by APR 5 April 2018
Linkedin